Magnetic Resonance - Technology Information Portal Welcome to MRI Technology
Info
  Sheets

Out-
      side
 



 
 't2' 
SEARCH FOR    
 
  2 3 5 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Result : Searchterm 't2' found in 8 terms [] and 150 definitions []
previous     51 - 55 (of 158)     next
Result Pages : [1 2]  [3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... ]
Searchterm 't2' was also found in the following services: 
spacer
News  (28)  Resources  (5)  Forum  (67)  
 
Gadopentetate DimeglumineInfoSheet: - Contrast Agents - 
Intro, Overview, 
Characteristics, 
Types of, 
etc.MRI Resource Directory:
 - Contrast Agents -
 
Short name: Gd-DTPA, generic name: Gadopentetate dimeglumine, chemical compound: Gadolinium-diethylenetriaminepentaacetic acid
Gadopentetate dimeglumine was introduced in 1981, as the first paramagnetic MRI contrast agent (ionic). The Gd-induced dipole dipole interactions lead to shortening of T1, which results in contrast enhancement on T1 weighted images. The used metal ion Gd3+ (gadolinium) is toxic, and therefore bound in the renally excreted DTPA chelate, a very stable complex. The Gd-complex also induce susceptibility effects, as a result of the magnetic field gradient between the contrast agent in the blood vessels and the surrounding tissue, that lead to shortening of T2 or T2*.
Following intravenous administration, the compound is distributed rapidly in the extracellular space and is eliminated unchanged by glomerular filtration via the kidneys. Up to 6 hours, post injection an average of 83% of the dose is eliminated renal.

See also Magnevist®, Gadolinium and Contrast Agents.
spacer
 
• Related Searches:
    • Bayer HealthCare Pharmaceuticals
    • DTPA
    • Gadolinium
    • Paramagnetic Contrast Agents
    • Paramagnetic Substance
 
Further Reading:
  Basics:
Magnevist Package Insert
2000
Gadopentetic acid
   by en.wikipedia.org    
  News & More:
EMA's final opinion confirms restrictions on use of linear gadolinium agents in body scans
Friday, 21 July 2017   by www.ema.europa.eu    
MRI Resources 
Societies - MRI Physics - Services and Supplies - Hospitals - Mobile MRI Rental - Breast Implant
 
Gastrointestinal Superparamagnetic Contrast AgentsInfoSheet: - Contrast Agents - 
Intro, Overview, 
Characteristics, 
Types of, 
etc.MRI Resource Directory:
 - Contrast Agents -
 
Gastrointestinal (GI) superparamagnetic contrast agents are used in MRI to improve the visualization of e.g., the intestinal tract, the pancreas (see MRCP), etc. Disadvantages are susceptibility artifacts e.g., dependent on delayed imaging or large volumes resulting in artifacts in the colon and distal small bowel loops related to higher concentration of the particles and absorption of the fluid.
Different types of MRI gastrointestinal superparamagnetic contrast agents:
Magnetite albumin microsphere

Usually gastrointestinal superparamagnetic contrast media consist of small iron oxide crystals (ferrites), which produce a signal reduction in the stomach and bowel after oral administration. The T2 shortening caused by these particles is produced from the local magnetic field inhomogeneities associated with the large magnetic moments of superparamagnetic particles. Ferrites are iron oxides of the general formula Fe203.MO, where M is a divalent metal ion and may be mixed with Fe3O4 in different preparations. Ferrites can produce symptoms of nausea after oral administration, as well as flatulence and a transient rise in serum iron. Embedding in inert substances reduce side effects by decreasing the absorption and interaction with body tissues. Combining these contrast materials with polymers such as polyethylene glycol or cellulose, or with sugars such as dextrose, results in improved T1 and/or T2 relaxivity compared with that of the contrast agent alone.

See also Negative Oral Contrast Agents, Gastrointestinal Diamagnetic Contrast Agents, Relaxivity, and Combination Oral Contrast Agents.
spacer

• View the DATABASE results for 'Gastrointestinal Superparamagnetic Contrast Agents' (6).Open this link in a new window

 
Further Reading:
  Basics:
Negative GI Contrast Agents
   by www.mritutor.org    
MRI Resources 
Open Directory Project - Stent - Raman Spectroscopy - Colonography - Anatomy - Quality Advice
 
Gradient Echo Multi SliceInfoSheet: - Sequences - 
Intro, 
Overview, 
Types of, 
etc.
 
(GEMS) This pulse sequence uses a changeable flip angle instead of a 90° pulse and a gradient instead of a RF pulse to rephase the FID.
T2*, T1 weighted and proton density images can be acquired. The flip angle in combination with the TR determines the T1 weighting and the TE controls the amount of dephasing. To minimize T2* the echo time should be short.

See also Gradient Echo Sequence.
spacer
Searchterm 't2' was also found in the following services: 
spacer
News  (28)  Resources  (5)  Forum  (67)  
 
Gradient Recalled Acquisition in Steady StateInfoSheet: - Sequences - 
Intro, 
Overview, 
Types of, 
etc.
 
(GRASS) This sequence is very similar to FLASH, except that the spoiler pulse is eliminated. As a result, any transverse magnetization still present at the time of the next RF pulse is incorporated into the steady state. GRASS uses a RF pulse that alternates in sign. Because there is still some remaining transverse magnetization at the time of the RF pulse, a RF pulse of a degree flips the spins less than a degree from the longitudinal axis. With small flip angles, very little longitudinal magnetization is lost and the image contrast becomes almost independent of T1. Using a very short TE eliminates T2* effects, so that the images become proton density weighted. As the flip angle is increased, the contrast becomes increasingly dependent on T1 and T2*. It is in the domain of large flip angles and short TR that GRASS exhibits vastly different contrast to FLASH type sequences.
spacer

• View the DATABASE results for 'Gradient Recalled Acquisition in Steady State' (4).Open this link in a new window

MRI Resources 
Chemistry - Knee MRI - Pathology - MRI Technician and Technologist Schools - Movies - Manufacturers
 
Image Selected In Vivo Spectroscopy
 
(ISIS) Image selected in vivo spectroscopy is used as a localization sequence to provide complete gradient controlled three-dimensional localization with a reduced number of sequence cycles, e.g. for in vivo 31P spectroscopy. The ISIS method generates three 180° pulses prior to a 90° pulse, after which the free induction decay is recorded. Specific 180° pulses (slice-selective) are combined and the FID's added or subtracted to generate a spectrum.
An advantage of the ISIS method is that the magnetization (before the final 90° pulse) is predominantly along the z-axis and so T2 effects are relatively small. This explains the value of this technique for 31P data acquisition, because some phosphorus metabolites (e.g. ATP) have short T2 values.
A disadvantage is that eight acquisitions are required to accomplish the spatial localization, therefore the sequence cannot be used for localized shimming. Another problem, because any variation between these data collections (for example, due to movement) will degrade these applications, can be solved by incorporating outer volume suppression techniques such as OSIRIS (modified ISIS).
spacer
MRI Resources 
Jobs - Diffusion Weighted Imaging - Abdominal Imaging - MRI Centers - IR - Manufacturers
 
previous      51 - 55 (of 158)     next
Result Pages : [1 2]  [3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... ]
 Random Page
 
Share This Page
FacebookTwitterLinkedIn

MR-TIP    
Community   
User
Pass
Forgot your UserID/Password ?    



MRI is trending to low field magnets :
reduced costs will lead to this change 
AI will close the gap to high field 
only in remote areas 
is only temporary 
never 

Look
      Ups





MR-TIP.com uses cookies! By browsing MR-TIP.com, you agree to our use of cookies.

Magnetic Resonance - Technology Information Portal
Member of SoftWays' Medical Imaging Group - MR-TIP • Radiology-TIP • Medical-Ultrasound-Imaging • 
Copyright © 2003 - 2024 SoftWays. All rights reserved. [ 21 November 2024]
Terms of Use | Privacy Policy | Advertising
 [last update: 2024-02-26 03:41:00]